Vendor review
Lumira reviews
Lumira reviews from 104 independent lab tests (Retatrutide, Tirzepatide and GHK-Cu): grade A, purity and fill accuracy. Is Lumira legit? See what its vials showed.
What the lab tests show
104 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Oct 14, 2026 | BPC-157 | 99.99 % | 9.44 mg of 10 mg (-6 %) | Pass | View |
| Oct 12, 2026 | HGH | 99.9 % | 30.2 iu of 24 iu (26 %) | Pass | View |
| Oct 12, 2026 | MOTS-c | 99.9 % | 9.4 mg of 10 mg (-6 %) | Pass | View |
| Oct 12, 2026 | hCG | 99.9 % | 5530 IU of 5000 IU (11 %) | Pass | View |
| Oct 9, 2026 | Retatrutide | 99.9 % | 4.99 mg of 5 mg (0 %) | Pass | View |
| Oct 8, 2026 | HGH | 99.9 % | 26.4 iu of 24 iu (10 %) | Pass | View |
| Oct 6, 2026 | BPC-157 | 97.78 % | 10.5852 mg of 10 mg (6 %) | Pass | View |
| Oct 6, 2026 | Retatrutide | 100 % | 12.729 mg of 10 mg (27 %) | Pass | View |
| Oct 6, 2026 | TB-500 | 10 mg | Fail | View | |
| Sep 30, 2026 | Retatrutide | 99.9 % | 19.99 mg of 20 mg (0 %) | Pass | View |
| Sep 24, 2026 | Retatrutide | 30 mg | Fail | View | |
| Sep 24, 2026 | Retatrutide | 99.9 % | 8.43 mg of 10 mg (-16 %) | Pass | View |
| Sep 24, 2026 | Ipamorelin | 97.7 % | 4.89 mg of 5 mg (-2 %) | Pass | View |
| Sep 23, 2026 | hCG | 49.7 % | 3130 IU of 5000 IU (-37 %) | Pass | View |
| Sep 17, 2026 | Retatrutide | 99.9 % | 19.6 mg of 20 mg (-2 %) | Pass | View |
| Sep 17, 2026 | Retatrutide | 99.9 % | 27.1 mg of 30 mg (-10 %) | Pass | View |
| Sep 17, 2026 | Retatrutide | 99.9 % | 15.4 mg of 15 mg (3 %) | Pass | View |
| Sep 14, 2026 | Tirzepatide | 99.9 % | 24.4 mg of 30 mg (-19 %) | Pass | View |
| Sep 9, 2026 | Retatrutide | 20 mg | Fail | View | |
| Sep 9, 2026 | GLOW | 99.9 % | 73.2 mg of 70 mg (5 %) | Pass | View |
| Sep 7, 2026 | Tirzepatide | 30 mg | Fail | View | |
| Sep 4, 2026 | HGH | 99.9 % | 21.4 Iu of 24 Iu (-11 %) | Pass | View |
| Sep 4, 2026 | HGH | 24 IU | Fail | View | |
| Aug 31, 2026 | Retatrutide | 99.7 % | 10.4 mg of 10 mg (4 %) | Pass | View |
| Aug 27, 2026 | Tirzepatide | 30 mg | Fail | View | |
| Aug 26, 2026 | Retatrutide | 99.9 % | 9.18 mg of 10 mg (-8 %) | Pass | View |
| Aug 25, 2026 | Tesamorelin | 99.8 % | 21.6 mg of 20 mg (8 %) | Pass | View |
| Aug 18, 2026 | Tirzepatide | 99.8 % | 20.8 mg of 20 mg (4 %) | Pass | View |
| Aug 18, 2026 | BPC-157 | 10 mg | Fail | View | |
| Aug 9, 2026 | BPC-157 | 99.6 % | 9.1 mg of 10 mg (-9 %) | Pass | View |
| Aug 9, 2026 | Retatrutide | 99.9 % | 25.2 mg of 30 mg (-16 %) | Pass | View |
| Aug 9, 2026 | TB-500 | 99.5 % | 8.6 mg of 10 mg (-14 %) | Pass | View |
| Aug 5, 2026 | GHK-Cu | 99.9 % | 92.8 mg of 100 mg (-7 %) | Pass | View |
| Aug 5, 2026 | Tirzepatide | 99.9 % | 28 mg of 30 mg (-7 %) | Pass | View |
| Aug 5, 2026 | Retatrutide | 99.9 % | 18.1 mg of 20 mg (-10 %) | Pass | View |
| Aug 5, 2026 | GHK-Cu | 99.9 % | 41.4 mg of 50 mg (-17 %) | Pass | View |
| Aug 5, 2026 | GHK-Cu | 99.9 % | 93.3 mg of 100 mg (-7 %) | Pass | View |
| Aug 5, 2026 | Retatrutide | 99.9 % | 9.05 mg of 10 mg (-10 %) | Pass | View |
| Aug 5, 2026 | TB-500 | 96.6 % | 9.62 mg of 10 mg (-4 %) | Pass | View |
| Aug 5, 2026 | Wolverine | 99 % | 9.34 mg of 10 mg (-7 %) | Pass | View |
| Aug 4, 2026 | Wolverine | 98.4 % | 9.96 mg of 10 mg (0 %) | Pass | View |
| Aug 3, 2026 | GHK-Cu | 99.9 % | 42.3 mg of 50 mg (-15 %) | Pass | View |
| Aug 3, 2026 | hCG | 99.9 % | 5050 IU of 5000 IU (1 %) | Pass | View |
| Jul 30, 2026 | Tirzepatide | 99.9 % | 32.4 mg of 30 mg (8 %) | Pass | View |
| Jul 22, 2026 | NAD+ | 500 mg | Fail | View | |
| Jul 20, 2026 | GLOW | 70 mg of 70 mg | View | ||
| Jul 20, 2026 | GLOW | 70 mg | Fail | View | |
| Jul 13, 2026 | Retatrutide | 99.9 % | 11.6 mg of 10 mg (16 %) | Pass | View |
| Jul 13, 2026 | BPC-157 | 5 mg | Fail | View | |
| Jul 13, 2026 | Retatrutide | 99.8 % | 21.4 mg of 20 mg (7 %) | Pass | View |
| Jul 13, 2026 | Retatrutide | 99.9 % | 4.36 mg of 5 mg (-13 %) | Pass | View |
| Jul 13, 2026 | GHK-Cu | 99.9 % | 71.4 mg of 100 mg (-29 %) | Pass | View |
| Jul 13, 2026 | TB-500 | 5 mg | Fail | View | |
| Jul 13, 2026 | Tesamorelin | 99.2 % | 5.45 mg of 5 mg (9 %) | Pass | View |
| Jul 13, 2026 | Ipamorelin | 99.8 % | 4.53 mg of 5 mg (-9 %) | Pass | View |
| Jul 1, 2026 | BPC-157 | 10 mg | Fail | View | |
| Jul 1, 2026 | GHK-Cu | 99.9 % | 42.3 mg of 50 mg (-15 %) | Pass | View |
| Jun 26, 2026 | NAD+ | 500 mg | Fail | View | |
| Jun 24, 2026 | TB-500 | 99.5 % | 5.6 mg of 5 mg (12 %) | Pass | View |
| Jun 24, 2026 | Retatrutide | 10 mg | Fail | View |
What Lumira sells
No current listings on record.
About Lumira
Finnrick has tested 104 samples from Lumira across 14 products.